Tauriga Hopes to Chew its Way to Higher Stock Prices
Investing is hard enough, AllPennyStocks.com tries to simplify the whole process. Join our free email newsletter!
Under $0.25 Momentum Plays, One Of Many Features Available On AllPennyStocks.com Pro.
Try It Free For 14 Days!

Tauriga Hopes to Chew its Way to Higher Stock Prices

Under $0.25 Momentum Plays, One Of Many Features Available On AllPennyStocks.com Pro.
Try It Free For 14 Days!
By: Dylan Sikes – AllPennyStocks.com News

Wednesday, February 6, 2019

The unlikeliest of products are still attracting investors to the companies who make those products. Wednesday, it was New York-based Tauriga Sciences, Inc. (OTC:TAUG) that got on its soap box.

The company, building its business through the development, distribution, and licensing of proprietary products as well as the evaluation of potential acquisition opportunities and equity investments, has today showcased its graphic design and artwork for the retail display box of its CBD Infused Gum; Branded as Tauri-Gum, set to launch commercially next month.

“Studies have shown,” reads today’s news release, “that a chewing gum product may provide a superior delivery method for distributing its key active ingredients (such as CBD), in comparison to other oral dosage forms, such as: pills, capsules, beverages, and gummies.  As an individual chews gum, the CBD is released from the gum quickly and is absorbed by the Oral Mucosa, rather than the Digestive System.”

Shares in TAUG gained 73-100ths of a cent, or 13.6%, to 6.1 cents, on volume of 389,000 shares.


Copyright © 2019 AllPennyStocks.com. All rights reserved. Republication or redistribution of AllPennyStocks.com's content is expressly prohibited without the prior written consent of AllPennyStocks.com. AllPennyStocks.com shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Other Penny Stock Movers

Online Jeweller Looks Poised To Retest All-Time Highs
Supernova Buys Refinery, Shares Take Off for Stars
Clothier Launches Website, Investors Respond
CardioComm Announces New Product, Shares Climb


Back to Top